Kieran O'Kane, Chief Commercial Officer at BIODESIX INC (BDSX), sold 584 shares at $10.08 ($6K) on 2026-02-10, disclosed to the SEC on 2026-02-11.
Seasonal sale ($6k) by Chief Commercial Officer — this insider has traded BDSX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BDSX | SELL | 2025-11-13 | $191 | — | Filing → |
| BDSX | SELL | 2025-08-14 | $200 | — | Filing → |
| BDSX | SELL | 2025-05-13 | $169 | — | Filing → |